» Articles » PMID: 30805010

Fine Tuning of Hepatocyte Differentiation from Human Embryonic Stem Cells: Growth Factor Small Molecule-Based Approaches

Overview
Journal Stem Cells Int
Publisher Wiley
Specialty Cell Biology
Date 2019 Feb 27
PMID 30805010
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Human embryonic stem cells (hESCs) are being utilized in diverse areas of studies such as development and disease modeling, cell replacement therapy, or drug toxicity testing because of their potential to be differentiated into any cell type in the body. The directed differentiation of hESCs into hepatocytes could provide an invaluable source of liver cells for various liver-based applications. Therefore, several protocols have been established in the past for hESC-hepatocyte differentiation based on the knowledge of signaling pathways and growth factors involved in different stages of embryonic hepatogenesis. Although successful derivation of hepatocytes has been achieved through these protocols, the efficiency is not always ideal. Herein, we have tested several combinations of published protocols, for example, growth factor vs. small molecule and different time durations of treatment for definitive endoderm (DE) induction and further hepatocyte differentiation to develop an efficient DE induction and hepatocyte differentiation in a highly reproducible manner based on the stage-specific marker expression and functional analysis.

Citing Articles

Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment.

Gupta S, Sharma A, Rajakannu M, Bisevac J, Rela M, Verma R Stem Cell Rev Rep. 2024; 20(8):2215-2235.

PMID: 39259445 PMC: 11554881. DOI: 10.1007/s12015-024-10771-x.


Novel Approaches to Studying SLC13A5 Disease.

Beltran A Metabolites. 2024; 14(2).

PMID: 38392976 PMC: 10890222. DOI: 10.3390/metabo14020084.


The cytotoxicity of gefitinib on patient‑derived induced pluripotent stem cells reflects gefitinib‑induced liver injury in the clinical setting.

Fujisaka Y, Nakagawa T, Tomoda K, Watanabe M, Matsunaga N, Tamura Y Oncol Lett. 2023; 26(6):520.

PMID: 37927418 PMC: 10623090. DOI: 10.3892/ol.2023.14108.


Colorectal cancer-derived small extracellular vesicles induce TGFβ1-mediated epithelial to mesenchymal transition of hepatocytes.

Pucci M, Moschetti M, Urzi O, Loria M, Conigliaro A, Di Bella M Cancer Cell Int. 2023; 23(1):77.

PMID: 37072829 PMC: 10114452. DOI: 10.1186/s12935-023-02916-8.


Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features.

Varghese D, Alawathugoda T, Sheikh M, Challagandla A, Emerald B, Ansari S Cell Death Dis. 2022; 13(8):670.

PMID: 35915082 PMC: 9343434. DOI: 10.1038/s41419-022-05125-9.


References
1.
Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J . Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284(5411):143-7. DOI: 10.1126/science.284.5411.143. View

2.
Tanimizu N, Miyajima A . Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci. 2004; 117(Pt 15):3165-74. DOI: 10.1242/jcs.01169. View

3.
Tanimizu N, Saito H, Mostov K, Miyajima A . Long-term culture of hepatic progenitors derived from mouse Dlk+ hepatoblasts. J Cell Sci. 2004; 117(Pt 26):6425-34. DOI: 10.1242/jcs.01572. View

4.
Clotman F, Jacquemin P, Plumb-Rudewiez N, Pierreux C, Van Der Smissen P, Dietz H . Control of liver cell fate decision by a gradient of TGF beta signaling modulated by Onecut transcription factors. Genes Dev. 2005; 19(16):1849-54. PMC: 1186184. DOI: 10.1101/gad.340305. View

5.
Schmelzer E, Wauthier E, Reid L . The phenotypes of pluripotent human hepatic progenitors. Stem Cells. 2006; 24(8):1852-8. DOI: 10.1634/stemcells.2006-0036. View